Detailed answers about POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK, including incorporation, status, business activity, and accounts information.
When was POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK founded?
POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK was officially incorporated on 2 December 2008 and is registered under company number 06763889. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK?
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK?
POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK do?
POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK operates in the following sector: 96090 - Other service activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK's registered address?
The registered office address of POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK is 15 STONELEIGH AVENUE, BRIGHTON, ENGLAND, BN1 8NP. This is the official address filed with Companies House for legal and statutory correspondence.
Is POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK financially stable?
The most recent accounts for POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK were made up to 31 March 2025, filed as MICRO ENTITY. Next accounts are due by 31 December 2026.